Market Overview - The market sentiment for August is pessimistic, with the Hang Seng Index closing down 1.07% [1] - The U.S. has finalized tariffs on various countries, with rates ranging from 10% to 41%, impacting global trade dynamics [1][2] - Canada faces a tariff increase to 35% on certain goods, leading to potential retaliatory measures [1] Economic Impact - The average tariff rate in the U.S. is expected to rise to 15.2%, significantly higher than previous levels, which may disrupt global supply chains [2] - Japan and Thailand are experiencing substantial impacts on their agricultural sectors due to U.S. tariffs on rice [2] Pharmaceutical Sector - U.S. President Trump has threatened 17 pharmaceutical companies with price reductions by September 29, causing significant stock declines in major firms [2] - Hong Kong-listed pharmaceutical companies also faced declines, reflecting the broader market impact [2] Industry Developments - The Hong Kong stablecoin initiative has seen limited licensing, affecting related stocks negatively [3] - The Chinese government is promoting consumption and service sectors, with companies like Xirui and Legend Holdings benefiting from this trend [5] Regulatory Changes - New regulations in the Chinese traditional medicine sector require all herbal products to have clear expiration dates, promoting safer practices [8] - The establishment of a unified national market in China is progressing, with logistics companies like Zhongtong Express seeing stock increases [6] Company Highlights - Goldwind Technology has secured significant contracts, indicating strong market competitiveness and a robust order backlog [10] - The company reported a 35.72% increase in revenue and a 70.84% increase in net profit for Q1 2025, driven by international expansion [10][11] - Goldwind's international business has grown, with a substantial share of orders coming from overseas markets [11]
智通港股解盘 | 关税落地破坏全球供应链 观察非农数据是否有惊喜